VIROMED MEDICAL AG

Viromed Medical AG secures Turkey approval for its ViroCAP® med cold‑plasma wound‑care device, opening a high‑growth market and testing its commercialization prowess.

Viromed’s ViroCAP med cold‑plasma device gains early Turkey approval, boosting wound‑care innovation and paving the way for expanded global adoption.

Viromed Medical AG raises €2.0 m by selling new shares, excluding existing shareholders, to fuel product expansion and strengthen its balance sheet.